Guidelines

The bill, which requires electronic prescribing of Schedules I through VI controlled substances, goes into effect Jan. 1, 2021.

Zydus Cadila's generic Janumet will give Type 2 diabetes patients another treatment option.

In addition to DIR fee reform, NACDS also is urging the development of standardized pharmacy quality metrics.

This month the AmerisourceBergen Foundation has supported more than 30 organizations through its Opioid Resource Grant Program and committed $25,000 to relief efforts in areas recently affected by tornadoes.

The FDA has approved a new indication for Dupixent, providing an option for patients age 12-to-17 years old with moderate to severe atopic dermatitis.

Alkem's generic Diovan is expected to help relieve a recent shortage of valsartan.

Adlon Therapeutics' Adhansia XR capsules offer a new option for ADHD patients.

The rivastigmine transdermal system had a market value of approximately $214 million for the 12 months ended January 2019.